CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Open-market buy Chief Technology Officer bought 15,000 shares at $1.65 ($24,750)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 83,333 shares at $1.20 ($100,000)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- S-1MEF Other S-1MEF
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Results of operations · Regulation FD disclosure
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 9 of 28 · 547 filings